- Potent ATP-competitive inhibitor of the TGF-β type I receptor ALK5
- Useful for cellular reprogramming and the culture of human pluripotent stem cells
- Active in vitroand in vivo
ALK5 inhibitor II is a cell permeable, potent, selective and ATP-competitive inhibitor of TGF-β RI kinase (IC50=23nM, 4nM and 18nM for binding, auto-phosphorylation, and cellular assay in HepG2 cells of TGF-β RI kinase, respectively). It minimally affects a panel of nine closely related kinases including p38 MAPKand GSK3 (IC50>16µM). It can be used for the induction of the pluripotency of stem cells by replacing the transcription factor SOX2 via the inhibition of TGF-β signaling and inducing the expression of the transcription factor Nanog.
Product Details
| Alternative Name: | TGF-β RI Kinase Inhibitor II, 2-(3-(6-Methylpyridin-2-yl)-1H-pyrazol-4-yl)-1,5-naphthyridine |
| |
| Formula: | C17H13N5 |
| |
| MW: | 287.3 |
| |
| CAS: | 446859-33-2 |
| |
| Purity: | ≥97% (HPLC) |
| |
| Identity: | Identity determined by NMR. |
| |
| Appearance: | White to off-white or yellow solid. |
| |
| Solubility: | Soluble in DMSO (5 mg/ml) or methanol (5 mg/ml). |
| |
| Shipping: | Ambient Temperature |
| |
| Long Term Storage: | -20°C |
| |
| Use/Stability: | Stable for 2 years after receipt when stored at -20°C. Stock solutions are stable for up to 6 months when stored at -20°C. |
| |
| Handling: | Protect from light. |
| |
| Regulatory Status: | RUO - Research Use Only |
| |
Please mouse over
Product Literature References
Insulin regulates human pancreatic endocrine cell differentiation in vitro: P. Cota, et al.; Mol. Metab.
79, 101853 (2023),
Abstract;
An HNF1α truncation associated with maturity-onset diabetes of the young impairs pancreatic progenitor differentiation by antagonizing HNF1β function: A. Cujba, et al.; Cell Rep.
38, 110425 (2022),
Abstract;
Full Text
Differentiation of beta-like cells from human induced pluripotent stem cell-derived pancreatic progenitor organoids: S. Pedraza-Arevalo, et al.; STAR Protoc.
3, 101656 (2022),
Abstract;
Full Text
Generation of isogenic hiPSCs with targeted edits at multiple intronic SNPs to study the effects of the type 2 diabetes associated KCNQ1 locus in American Indians: A.K. Nair, et al.; Cells
11, 1446 (2022),
Abstract;
Full Text
Angiopoietins stimulate pancreatic islet development from stem cells: S. S. Karanth, et al.; Sci. Rep.
11, 13558 (2021),
Abstract;
Generation of insulin-producing pancreatic β cells from multiple human stem cell lines: N.J. Hogrebe, et al.; Nat. Protoc.
16, 4109 (2021),
Abstract;
Selective deletion of human leukocyte antigens protects stem cell-derived islets from immune rejection: A.V. Parent, et al.; Cell Rep.
36, 109538 (2021),
Abstract;
The postnatal pancreatic microenvironment guides β cell maturation through BMP4 production: L. Sakhneny, et al.; Dev. Cell
56, 2703 (2021),
Abstract;
A human ESC-based screen identifies a role for the translated lncRNA LINC00261 in pancreatic endocrine differentiation: B. Gaertner, et al.; Elife.
9, e58659 (2020),
Abstract;
Full Text
A non-coding disease modifier of pancreatic agenesis identified by genetic correction in a patient-derived iPSC line: S. Kishore, et al.; Cell Stem Cell
27, 137 (2020),
Abstract;
Full Text
A specialized niche in the pancreatic microenvironment promotes endocrine differentiation: C. Cozzitorto, et al.; Dev. Cell
55, 150 (2020),
Abstract;
Full Text
BCL-xL/BCL2L1 is a critical anti-apoptotic protein that promotes the survival of differentiating pancreatic cells from human pluripotent stem cells: L.S.W. Loo, et al.; Cell Death Dis.
11, 378 (2020),
Abstract;
Full Text
Bioinformatic analyses of miRNA–mRNA signature during hiPSC differentiation towards insulin-producing cells upon HNF4α mutation: L. Ghila, et al.; Biomedicines
8, 179 (2020),
Abstract;
Full Text
Generation of pancreatic β cells from CD177+ anterior definitive endoderm: P.U. Mahaddalkar, et al.; Nat. Biotechnol.
38, 1061 (2020),
Abstract;
Human T cells expressing a CD19 CAR-T receptor provide insights into mechanisms of human CD19-Positive β cell destruction: H. Ma, et al.; Cell Rep. Med.
1, 100097 (2020),
Abstract;
Full Text
Modeling type 1 diabetes in vitro using human pluripotent stem cells: N.C. Leite, et al.; Cell Rep.
32, 107894 (2020),
Abstract;
Full Text
Single-cell lineage analysis reveals extensive multimodal transcriptional control during directed beta-cell differentiation: C. Weng, et al.; Nat. Metab.
2, 1443 (2020),
Abstract;
Full Text
Targeting the cytoskeleton to direct pancreatic differentiation of human pluripotent stem cells: N.J. Hogrebe, et al.; Nat. Biotechnol.
38, 460 (2020),
Abstract;
Full Text
A hydrogel platform for in vitro three dimensional assembly of human stem cell-derived islet cells and endothelial cells: P. Augsornworawat, et al.; Acta Biomater.
97, 272 (2019),
Abstract;
Acquisition of Dynamic Function in Human Stem Cell-Derived β Cells: L. Velazco-Cruz, et al.; Stem Cell Reports
12, 351 (2019),
Application(s): Treatment of hESC culture,
Abstract;
Full Text
Glucose-Responsiveness of Pancreatic β-Like (GRP β-L) Cells Generated from Human Pluripotent Stem Cells: B. Rajaei, et al.; Curr. Protoc. Hum. Genet.
100, e71 (2019),
Abstract;
Point mutations in the PDX1 transactivation domain impair human β-cell development and function: X. Wang, et al.; Mol. Metab.
24, 80 (2019),
Abstract;
Full Text
Generation and selection of pluripotent stem cells for robust differentiation to insulin-secreting cells capable of reversing diabetes in rodents: S.M. Southard, et al.; PLoS One
9, e0203126 (2018),
Abstract;
Full Text
Intrinsic Immunity Shapes Viral Resistance of Stem Cells: X. Wu, et al.; Cell
3, 423 (2018),
Abstract;
Full Text
Modeling signaling-dependent pluripotency with Boolean logic to predict cell fate transitions: A. Yachie-Kinoshita, et al.; Mol. Syst. Biol.
14, e7952 (2018),
Abstract;
Full Text
Cultured circulating tumor cells and their derived xenografts for personalized oncology: R. Wang, et al.; Asian J. Urol.
4, 240 (2016),
Abstract;
Full Text
Economic 3D-printing approach for transplantation of human stem cell-derived β-like cells: J. Song, et al.; Biofabrication
9, 015002 (2016),
Abstract;
ERRγ Is required for the metabolic maturation of therapeutically functional glucose-responsive β cells: E. Yoshihara, et al.; Cell Metab.
23, 622 (2016),
Abstract;
Full Text
Long-term glycemic control using polymer-encapsulated human stem cell-derived beta cells in immune-competent mic: A.J. Vegas, et al.; Nat. Med.
22, 306 (2016),
Abstract;
Full Text
Emdogain-regulated gene expression in palatal fibroblasts requires TGF-βRI kinase signaling: A. Stähli, et al.; PLoS One
9, e105672 (2014),
Abstract;
Full Text
Generation of functional human pancreatic β cells in vitro: F.W. Pagliuca, et al.; Cell
159, 428 (2014),
Abstract;
Full Text
Reversal of diabetes with insulin-producing cells derived in vitro from human pluripotent stem cells: A. Rezania, et al.; Nat. Biotechnol.
32, 1121 (2014),
Application(s): Treatment of human iPSC-derived pancreatic endocrine precursors,
Abstract;
Inhibitors of Src and focal adhesion kinase promote endocrine specification: impact on the derivation of β-cells from human pluripotent stem cells: I. Afrikanova, et al.; J. Biol. Chem.
286, 36042 (2011),
Abstract;
Full Text
A small-molecule inhibitor of tgf-Beta signaling replaces sox2 in reprogramming by inducing nanog: J.K. Ichida, et al.; Cell Stem Cell
5, 491 (2009),
Abstract;
Identification of 1,5-naphthyridine derivatives as a novel series of potent and selective TGF-beta type I receptor inhibitors: F. Gellibert, et al.; J. Med. Chem.
47, 4494 (2004),
Abstract;
Related Products
